Literature DB >> 28185069

Comment on: "Proactive Regional Pharmacovigilance System Versus National Spontaneous Reporting for Collecting Safety Data on Concerning Off-Label Prescribing Practices: An Example with Baclofen and Alcohol Dependence in France".

Alain Braillon1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28185069     DOI： 10.1007/s40264-017-0512-7

Source DB:  PubMed          Journal:  Drug Saf        ISSN： 0114-5916            Impact factor:   5.606


× No keyword cloud information.
  6 in total

1.  The long-term effect of a population-based life-style intervention on smoking and alcohol consumption. The Inter99 Study--a randomized controlled trial.

Authors:  Sophie Baumann; Ulla Toft; Mette Aadahl; Torben Jørgensen; Charlotta Pisinger
Journal:  Addiction       Date:  2015-08-19       Impact factor: 6.526

2.  Efficacy and safety of high-dose baclofen for the treatment of alcohol dependence: A multicentre, randomised, double-blind controlled trial.

Authors:  Esther M Beraha; Elske Salemink; Anna E Goudriaan; Abraham Bakker; David de Jong; Natasha Smits; Jan Willem Zwart; Dick van Geest; Pieter Bodewits; Tom Schiphof; Harma Defourny; Mirjam van Tricht; Wim van den Brink; Reinout W Wiers
Journal:  Eur Neuropsychopharmacol       Date:  2016-11-11       Impact factor: 4.600

3.  Off-Label Drug Use: Whose Interests Are Served?

Authors:  Alain Braillon; Joel Lexchin
Journal:  Am J Med Qual       Date:  2016-02-25       Impact factor: 1.852

4.  Proactive Regional Pharmacovigilance System Versus National Spontaneous Reporting for Collecting Safety Data on Concerning Off-Label Prescribing Practices: An Example with Baclofen and Alcohol Dependence in France.

Authors:  Marine Auffret; Julien Labreuche; Alain Duhamel; Sylvie Deheul; Olivier Cottencin; Régis Bordet; Sophie Gautier; Benjamin Rolland
Journal:  Drug Saf       Date:  2017-03       Impact factor: 5.606

5.  Severe Central Sleep Apnea Associated With Chronic Baclofen Therapy: A Case Series.

Authors:  Pierre-Yves Olivier; Marie Joyeux-Faure; Thibaut Gentina; Sandrine H Launois; Marie Pia d'Ortho; Jean-Louis Pépin; Frédéric Gagnadoux
Journal:  Chest       Date:  2016-05       Impact factor: 9.410

6.  The "Temporary Recommendations for Use": A dual-purpose regulatory framework for off-label drug use in France.

Authors:  Albane Degrassat-Théas; François Bocquet; Martine Sinègre; Jérôme Peigné; Pascal Paubel
Journal:  Health Policy       Date:  2015-09-25       Impact factor: 2.980
  6 in total
  1 in total

1.  Authors' Reply to Alain Braillon's Comment on "Proactive regional pharmacovigilance system versus national spontaneous reporting for collecting safety data on concerning off-label prescribing practices: An example with baclofen and alcohol dependence in France''.

Authors:  Marine Auffret; Julien Labreuche; Alain Duhamel; Sylvie Deheul; Olivier Cottencin; Régis Bordet; Sophie Gautier; Benjamin Rolland
Journal:  Drug Saf       Date:  2017-04       Impact factor: 5.606
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.